The Funding Model for Cancer Innovation is Broken — We Can Fix It - MedCity News
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.| MedCity News
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.| MedCity News
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees with the regulator’s position and will oppose the FTC’s challenge.| MedCity News
presented by | MedCity News
